407
staff
Melissa Stevens
Melissa Stevens is executive vice president of philanthropy at the Milken Institute, leading its
work with individual and family philanthropists and foundations seeking to deploy resources to make a transformative, sustainable impact.
+ Read More
staff
Kelsey Barcomb, PhD
Kelsey Barcomb, PhD, is a senior associate with MI Philanthropy’s Science Philanthropy Accelerato
r for Research and Collaboration (SPARC), and serves as a program manager at Breakthrough Discoveries for Thriving with Bipolar Disorder (BD2).
+ Read More
staff
Heather Haines
Heather Haines is director of convening and engagement at the Milken Institute Center for Strateg
ic Philanthropy. She joined the Institute from the International Fund for Animal Welfare, where she oversaw global events.
+ Read More
staff
Caitlyn Barrett, PhD
Caitlyn Barrett, PhD, is an director for MI Philanthropy.
staff
Katherine Sacks, PhD
Katherine Sacks is an Associate Director in health economics within the Research Department.
report
Giving Smarter: Philanthropic Opportunities to Advance Bipolar Disorder Research
People of all ages, ethnicities, and backgrounds endure the intense shifts in mood and energy level
s bipolar disorder (BD) causes.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
report
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes t
o mind. However, technology and devices are proving to be valuable options for treating intractable illnesses.
+ Read More
report
Solving the Philanthropist's Dilemma
Philanthropic capital has played and will continue to play a critical role as we rebuild after the
pandemic.
+ Read More
report
Infrastructure, Readiness, and Resilience: A Long-Term, Biomedical Systems-Based Response to COVID-19
Throughout the COVID-19 crisis, scientists, policymakers, health-care workers, and average citizens
worldwide mobilized in ways never seen before to mitigate the challenge at hand.
+ Read More
report
Type 1 Diabetes Autoantibody Screening: A Roadmap for Pediatric Policy Implementation
Type 1 diabetes, or T1D, once commonly known as juvenile diabetes, is an autoimmune disease in whic
h the immune system attacks the insulin-producing cells of the pancreas.
+ Read More
report
Bladder Cancer - A Giving Smarter Guide
More than 500,000 people in the US suffer from bladder cancer. At the time of this report, it
was the fifth most common cancer in the US. It is also the most expensive cancer to treat and frequently reoccurs.
+ Read More